Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
SAGE THERAPEUTIC RG (NQ: SAGE)
141.19 USD  -4.30 (-2.96%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 24, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 404,350
Open 146.17
Bid (Size) 141.20 (100)
Ask (Size) 143.22 (100)
Prev. Close 145.49
Today's Range 140.93 - 147.19
52wk Range 59.57 - 195.97
Shares Outstanding 45,777,940
Dividend Yield N/A
Performance
YTD
-15.28%
-15.28%
1 Month
-13.76%
-13.76%
3 Month
-21.79%
-21.79%
6 Month
+128.94%
+128.94%
1 Year
+93.81%
+93.81%
Top News
More News
Sage Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 3, 2018
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the company... Read More
from Business Wire News Releases
Sage Therapeutics Submits New Drug Application to U.S. FDA for Intravenous Brexanolone in the Treatment of Postpartum Depression
Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced the Company has... Read More
from Business Wire News Releases
More News
Read More
GrubHub, Nektar Among Top Tech Stocks Trouncing The Market
from Investor's Business Daily
Sage Therapeutics to Present Brexanolone Postpartum Depression Data and SAGE-217 Major Depressive Disorder Data at Upcoming Spring Medical Meetings
from Business Wire News Releases
Benzinga Pro's 5 Stocks To Watch Today
category Benzinga , GOOG , CBI , and 10 more.
from Benzinga
BRIEF-Sage Therapeutics Submits New Drug Application To U.S. FDA For Intravenous Brexanolone In The Treatment Of Postpartum Depression
category companyNews
from Reuters: Company News
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
from Business Wire News Releases
Notable Friday Option Activity: FLXN, HSIC, SAGE
category Stocks
from Market News Video
SPDR Portfolio Small Cap ETF Experiences Big Inflow
category ETFs
from ETF Channel
Why Stanley Black & Decker, ManpowerGroup, and Sage Therapeutics Slumped Today
category MAN , SAGE , SWK
from Motley Fool
Sage Therapeutic Crosses Below its 10-day MA (SAGE)
from Comtex SmarTrend® News Briefs
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial